Navigation Links
Substance P in hippocampus versus striatal marginal division for learning/memory function
Date:7/11/2014

In addition to the hippocampus, the marginal division of the striatum is also involved in learning and memory. What is the impact degree of substance P in the striatal marginal division on learning and memory function? Yan Yu and his team, College of Biophotonics, South China Normal University, China found, using immunofluorescence staining, that substance P receptor, neurokinin 1 was highly expressed in the hippocampus and striatal marginal division of normal rats. Unilateral or bilateral injection of an antisense oligonucleotide against neurokinin 1 receptor mRNA in the rat hippocampus or marginal division of the striatum effectively reduced neurokinin 1 receptor expression, and rat learning and memory function was significantly decreased. The authors considered that marginal division of the striatum plays a similar function in learning and memory to the hippocampus. Related results were published in Neural Regeneration Research (Vol. 9, No. 8, 2014).


'/>"/>

Contact: Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
Source:Eurekalert  

Page: 1

Related biology news :

1. Methane climate change risk suggested by proof of redox cycling of humic substances
2. Beer marinade could reduce levels of potentially harmful substances in grilled meats
3. New perspective for soil clean-up: Microscopic ciliates transport poisonous tar substances
4. Recovering valuable substances from wastewater
5. New discovery solves problem of anti-inflammatory substance
6. Substance in photosynthesis was at work in ancient, methane-producing microbes
7. Alzheimer substance may be the nanomaterial of tomorrow
8. Toxic substances in banana plants kill root pests
9. Direct link established between stimulus-response learning and substance abuse
10. New substance effectively combats multi-resistant bacteria
11. Vinyl flooring linked to potentially harmful substances at schools and daycare centers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Substance P in hippocampus versus striatal marginal division for learning/memory function
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour ... from the Q1 wave of its quarterly wearables survey. ... receptivity to a program where they would receive discounts ... company. "We were surprised to see that ... LaColla , CEO of Troubadour Research, "primarily because there ...
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, ... second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical ... eBook by providing practical tips, tools, and strategies for clinical researchers. , “The ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology: